The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor‐positive breast cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|137|3|686-697

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.3, 2015-08, pp. : 686-697

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract